MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Alteration of early endosomal trafficking causes neurodegeneration in PARK20

    C. Criscuolo, D. Fasano, V. Coppola, G. Amodio, M. Picillo, A. De Rosa, V. Bonifati, P. Barone, M. Pellecchia, G. De Michele, P. Remondelli, S. Paladino (Naples, Italy)

    Objective: To elucidate the molecular basis of the Park20 by evaluating the role of synaptojanin 1 in intracellular trafficking. Background: Recently a new form of…
  • 2017 International Congress

    Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging

    J. Infante, M. Sierra, I. Martínez-Rodríguez, P. Sánchjez-Juan, I. González-Aramburu, M. Jimenez-Alonso, A. Sánchez-Rodriguez, I. Banzo (Santander, Spain)

    Objective: To assess whether any of the biomarkers studied (UPDRS-III, SN echogenicity, UPSIT and DaT-SPECT) in a baseline evaluation of a cohort of LRRK2 G2019S asymptomatic…
  • 2017 International Congress

    Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease

    A. Ivashynka, S. Likhachev (Minsk, Belarus)

    Objective: Genetic testing Parkin (PARK 2) gene in patients with young-onset Parkinson's disease in Belarus. Background: The diagnosis of young-onset Parkinson's disease (PD) is the same…
  • 2017 International Congress

    Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients

    L. R'Bibo, S. Hamed, H. Houlden, N. Wood (London, United Kingdom)

    Objective: We aim to estimate the frequency of mutations in the glucocerebrosidase gene (GBA) and LRRK2 G2019S in a yet unstudied Egyptian Parkinson's disease population from the…
  • 2017 International Congress

    Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease

    d. BOBBILI, P. MAY, R. KRUEGER (Esch-sur-Alzette, Luxembourg)

    Objective: To unravel the genetic factors that play a role in PD we used the whole exome sequencing data available as a part of Parkinson…
  • 2017 International Congress

    Interest in Genetic Testing in Parkinson’s disease patients with DBS

    A. Fraint, G. Pal, C. Timms, E. Tam, R. Bhavsar, L. Verhagen, D. Hall, K. Marder (Chicago, IL, USA)

    Objective: To determine interest in genetic testing among Parkinson’s disease (PD) patients with deep brain stimulation (DBS). Background: Nearly 27% of patients with early-onset PD…
  • 2017 International Congress

    The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the south-eastern Moravia, Czech Republic.

    K. Mensikova, R. Vodicka, K. Kolarikova, T. Bartonikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the genetic background in the pedigrees with identified autosomal-dominant inheritance of parkinsonism. Background: Increased prevalence of parkinsonism with cognitive deterioration was detected…
  • 2017 International Congress

    Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

    G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…
  • 2017 International Congress

    Genetic, epigenetic and expression profiles in alpha-synucleinopathies

    E. Scott, I. Guella, A. Rajput, A. Rajput, L. Parkkinen, M. Kobor, M. Farrer (Vancouver, BC, Canada)

    Objective: To determine whether each of the alpha-synucleinopathies has distinct methylation and/or expression profiles that distinguishes them from other disorders in this class. Background: The…
  • 2017 International Congress

    Exome sequencing in patients with impulse control disorders in Parkinson’s disease: a pilot study

    S. Prud'hon, F. Danjou, S. Bekadar, Y. Marie, A. Rastetter, J. Guégan, F. Cormier-Dequaire, S. Lesage, A. Brice, J.-c. Corvol (Paris, France)

    Objective: To identify genetic variants associated with impulse control disorders (ICD) in Parkinson’s disease (PD) Background: ICD is frequently associated with dopamine agonist (DA) therapy…
  • « Previous Page
  • 1
  • …
  • 1681
  • 1682
  • 1683
  • 1684
  • 1685
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley